ATI Physical Therapy (ATIP) Competitors $5.50 +0.12 (+2.23%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends ATIP vs. ENZ, XGN, CCM, BNR, TOI, RNLX, OPGN, PMD, BRTX, and MRAIShould you be buying ATI Physical Therapy stock or one of its competitors? The main competitors of ATI Physical Therapy include Enzo Biochem (ENZ), Exagen (XGN), Concord Medical Services (CCM), Burning Rock Biotech (BNR), Oncology Institute (TOI), Renalytix (RNLX), OpGen (OPGN), Psychemedics (PMD), BioRestorative Therapies (BRTX), and Marpai (MRAI). These companies are all part of the "healthcare" industry. ATI Physical Therapy vs. Enzo Biochem Exagen Concord Medical Services Burning Rock Biotech Oncology Institute Renalytix OpGen Psychemedics BioRestorative Therapies Marpai ATI Physical Therapy (NYSE:ATIP) and Enzo Biochem (NYSE:ENZ) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, valuation, community ranking, media sentiment, dividends, risk, profitability and institutional ownership. Does the media favor ATIP or ENZ? In the previous week, Enzo Biochem had 7 more articles in the media than ATI Physical Therapy. MarketBeat recorded 8 mentions for Enzo Biochem and 1 mentions for ATI Physical Therapy. ATI Physical Therapy's average media sentiment score of 0.50 beat Enzo Biochem's score of 0.28 indicating that ATI Physical Therapy is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ATI Physical Therapy 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Enzo Biochem 0 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Which has more volatility & risk, ATIP or ENZ? ATI Physical Therapy has a beta of 0.41, suggesting that its share price is 59% less volatile than the S&P 500. Comparatively, Enzo Biochem has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Do analysts prefer ATIP or ENZ? Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score ATI Physical Therapy 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/AEnzo Biochem 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the MarketBeat Community prefer ATIP or ENZ? Enzo Biochem received 197 more outperform votes than ATI Physical Therapy when rated by MarketBeat users. Likewise, 55.64% of users gave Enzo Biochem an outperform vote while only 36.59% of users gave ATI Physical Therapy an outperform vote. CompanyUnderperformOutperformATI Physical TherapyOutperform Votes1536.59% Underperform Votes2663.41% Enzo BiochemOutperform Votes21255.64% Underperform Votes16944.36% Which has better earnings and valuation, ATIP or ENZ? Enzo Biochem has lower revenue, but higher earnings than ATI Physical Therapy. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioATI Physical Therapy$699.02M0.04-$69.79M-$13.61-0.41Enzo Biochem$31.91M1.85$20.29MN/AN/A Is ATIP or ENZ more profitable? ATI Physical Therapy has a net margin of -5.38% compared to Enzo Biochem's net margin of -81.73%. ATI Physical Therapy's return on equity of 0.00% beat Enzo Biochem's return on equity.Company Net Margins Return on Equity Return on Assets ATI Physical Therapy-5.38% N/A -3.96% Enzo Biochem -81.73%-11.84%-8.31% Do institutionals and insiders believe in ATIP or ENZ? 72.6% of ATI Physical Therapy shares are held by institutional investors. Comparatively, 36.9% of Enzo Biochem shares are held by institutional investors. 3.3% of ATI Physical Therapy shares are held by insiders. Comparatively, 15.5% of Enzo Biochem shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryEnzo Biochem beats ATI Physical Therapy on 7 of the 13 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get ATI Physical Therapy News Delivered to You Automatically Sign up to receive the latest news and ratings for ATIP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ATIP vs. The Competition Export to ExcelMetricATI Physical TherapyNursing & personal care facilities IndustryMedical SectorNYSE ExchangeMarket Cap$24.77M$523.72M$5.33B$19.27BDividend YieldN/AN/A5.07%3.53%P/E Ratio-0.4116.09128.5843.29Price / Sales0.040.241,490.3714.55Price / Cash0.954.8839.6220.89Price / Book-0.231.574.765.40Net Income-$69.79M-$225.94M$118.92M$985.39M7 Day Performance-4.41%7.17%0.78%-0.71%1 Month Performance-7.86%5.32%5.62%-0.98%1 Year Performance-23.51%-13.94%36.67%25.02% ATI Physical Therapy Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ATIPATI Physical Therapy1.6517 of 5 stars$5.50+2.2%N/A-19.3%$24.20M$699.02M-0.405,600Upcoming EarningsShort Interest ↓News CoverageENZEnzo Biochem0.5822 of 5 stars$1.13-1.7%N/A-15.7%$59.03M$31.91M0.00520Dividend AnnouncementAnalyst ForecastNews CoverageXGNExagen4.1971 of 5 stars$2.57+5.8%$7.00+172.4%+48.6%$44.69M$52.55M-2.65220Negative NewsCCMConcord Medical Services1.6687 of 5 stars$7.89+2.2%N/AN/A$34.26M$75.69M0.00970Analyst ForecastShort Interest ↓News CoverageGap DownBNRBurning Rock Biotech0.7289 of 5 stars$2.71-3.6%N/A-70.3%$27.75M$75.70M-0.561,390Gap DownTOIOncology Institute2.3103 of 5 stars$0.30-3.2%$2.50+733.6%-85.7%$22.64M$324.24M-0.38660Gap DownRNLXRenalytix1.2397 of 5 stars$0.21+5.7%$3.00+1,348.6%-79.7%$17.18M$2.29M-0.53100Gap UpOPGNOpGenN/A$1.81+8.4%N/A-72.0%$15.10M$2.67M0.00100Analyst ForecastNews CoverageGap UpPMDPsychemedicsN/A$2.32-0.4%N/A-6.5%$13.67M$20.79M-2.97140Positive NewsHigh Trading VolumeBRTXBioRestorative Therapies4.0457 of 5 stars$1.58+1.3%$18.00+1,039.2%-12.2%$10.93M$150,000.00-0.777Short Interest ↓Positive NewsMRAIMarpaiN/A$0.72-23.4%$6.00+733.3%+76.9%$9.89M$37.15M-0.22150 Related Companies and Tools Related Companies ENZ Alternatives XGN Alternatives CCM Alternatives BNR Alternatives TOI Alternatives RNLX Alternatives OPGN Alternatives PMD Alternatives BRTX Alternatives MRAI Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:ATIP) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | SponsoredWall St. Legend: Millions of Americans About to Fall Out of the 1%Wall Street insider reveals the financial tidal wave about to knock millions of Americans out of the One Perce...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ATI Physical Therapy, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ATI Physical Therapy With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.